Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
38 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61346 |
| ACT ENALAPRIL | 4MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61352 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-10-02 | 2019-02-01 | 24103 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-10-02 | 2019-02-01 | 24106 |
| ACT ETIDROCAL | 400MG 500MG | TABLET | Actual shortage | 2018-08-01 | 2019-02-21 | 57207 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2018-12-04 | 2019-03-12 | 68599 |
| ACT ENALAPRIL | 8MG | TABLET | Resolved | 2018-09-12 | 2019-03-12 | 61343 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-02-05 | 2019-03-12 | 74792 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2018-11-20 | 2019-03-12 | 67246 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2018-11-20 | 2019-03-12 | 67243 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2018-12-04 | 2019-03-14 | 68592 |
| ACT LOVASTATIN | 20MG | TABLET | Actual shortage | 2018-10-23 | 2019-03-14 | 65510 |
| ACT LOVASTATIN | 40MG | TABLET | Actual shortage | 2018-10-23 | 2019-03-14 | 65513 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2017-03-13 | 2019-04-11 | 1035 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-13 | 2019-04-11 | 1026 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68619 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68622 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-08-31 | 2019-04-11 | 59708 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-08-31 | 2019-04-11 | 59711 |
| TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2018-11-20 | 2019-04-11 | 67219 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |